News &amp; Updates

Drug-coated balloon (DCB) angioplasty and repeat stenting with drug-eluting stent (DES) show comparable safety and effectiveness in the treatment of patients with bare-metal stent (BMS) coronary in-stent restenosis (ISR) at 3 years, according to a study.

DCB angioplasty vs DES implantation: Which is better in coronary stent restenosis?

Atrial fibrillation patients less physically active than healthy people

02 Jun 2020 by

Patients with atrial fibrillation (AF) appear to engage in lesser daily physical activity than their healthy counterparts, according to a new study.

Atrial fibrillation patients less physically active than healthy people

Hospital food intake prognostic of mortality in heart failure patients

Among hospitalized heart failure patients, inadequate food intake raises a red flag on all-cause mortality or readmission within 1 year, a study has found.

Hospital food intake prognostic of mortality in heart failure patients

Long-duration high-dose folic acid supplementation ups risk of gestational hypertension

Use of high dose folic acid supplements from prepregnancy to midpregnancy may contribute to an increased risk of gestational hypertension, a recent study has shown.

Long-duration high-dose folic acid supplementation ups risk of gestational hypertension

Familial hypercholesterolaemia not a trigger of elevated lipoprotein(a)

Familial hypercholesterolaemia (FH) does not lead to an elevated lipoprotein(a), suggest the results of a recent study. Rather, elevated lipoprotein(a) increases the chance that an individual with genetic FH will be clinically diagnosed.

Familial hypercholesterolaemia not a trigger of elevated lipoprotein(a)

Fischer’s ratio predicts cardiac events in HF patients

Fischer’s ratio (FR)―the ratio of branched-chain amino acids (BCAA) to aromatic amino acids (AAA)―appears to be helpful in predicting cardiac events in patients with heart failure (HF), a recent study has found.

Fischer’s ratio predicts cardiac events in HF patients

Mavacamten improves symptoms in nonobstructive hypertrophic cardiomyopathy

The novel myosin inhibitor mavacamten is well tolerated in patients with symptomatic nonobstructive hypertrophic cardiomyopathy (nHCM) and leads to a significant decrease in N-terminal pro–B-type natriuretic peptide (NT-proBNP) and cardiac troponin I (cTnI), which suggests improvement in myocardial wall stress, a study has shown.

Mavacamten improves symptoms in nonobstructive hypertrophic cardiomyopathy

Outdoor temperature inversely tied to cardio-cerebrovascular event morbidity

The association between outdoor temperature and cardio-cerebrovascular events risk is mediated by temperature-driven blood pressure (BP), according to a study.

Outdoor temperature inversely tied to cardio-cerebrovascular event morbidity